Japan: Examining the first biosimilar patent litigation

In Japan, effectiveness and efficacy have been observed in breast cancer where overexpression of HER 2 was seen and in unresectable advanced or recurrent gastric cancer where overexpression of HER 2 w…
( read original story …)


Related Post

TOKYO | Japan space explorer arrives on asteroid t...
views 71
TOKYO —A Japanese space explorer arrived at an ast...
Japan beats All Whites in international football f...
views 233
The All Whites have been beaten 2‑1 by Japan in we...
Qualifier Diyas wins maiden WTA title in Tokyo
views 229
TOKYO (Reuters) - Zarina Diyas made it second time...
In Japan, heated tobacco associated with greater r...
views 228
Because those hikes were framed as a way to promot...
Matsuda dominates in Osaka on marathon debut | iaa...
views 174
Technical Certification system IAAF CERTIFICATES -...
Caught between Trump and North Korea, Japan is ner...
views 281
North Korea’s nuclear test, by far its largest, ca...
Japan’s central bank governor says economic ...
views 151
Bank of Japan Governor Haruhiko Kuroda said on Tue...
Meet the robot dinosaurs a Japanese company wants ...
views 281
Japanese firm On-Art Corp. unveiled human-operated...
Exclusive: Lockheed Martin to propose stealthy hyb...
views 122
TOKYO (Reuters) - U.S. defense contractor Lockheed...
Tsunami hits Japan after strong quake near Fukushi...
views 260
Tohoku Electric Power Co said there was no damage ...